Form 4 for GH Guardant Health, Inc.

Accepted 2025-06-20 00:00:00 ET · period of report 2025-06-17 · accession 0001576280-25-000193 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2025-06-20	2025-06-17	GH	CLARK IAN T	Dir	S - Sale	$48.38	-6,672	9,851	-40%	-$322.8K
DM	2025-06-20	2025-06-18	GH	CLARK IAN T	Dir	A - Grant	$0.00	+11.9K	6,833	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-06-17	S	D	6,672	$48.38	9,851	I By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account	—	—	(F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.38 to $48.41 per shares, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2	Derivative	Restricted Stock Units	2025-06-18	A	A	5,092	$0.00	5,092	D	$0.00 · — to —	5,092 Common Stock	(F3) The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier. (F4) Not applicable for Restricted Stock Units.
3	Derivative	Stock Option (Right to Buy)	2025-06-18	A	A	6,833	$0.00	6,833	D	$50.57 · — to 2035-06-18	6,833 Common Stock	(F2) The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier.